Trials / Completed
CompletedNCT02249065
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 205 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to: 1. assess the signs and symptoms of rosacea, including erythema, without treatment and during treatment with Mirvaso® gel 2. further characterize lifestyle impact and patient satisfaction with Mirvaso® treatment 3. gain a better understanding of the real-world use of Mirvaso® on the pattern and management of facial erythema of rosacea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brimonidine |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2014-09-25
- Last updated
- 2022-08-01
- Results posted
- 2017-10-19
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02249065. Inclusion in this directory is not an endorsement.